COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,226 Articles (22,733 medRxiv, 8,493 bioRxiv)

Most recent first Previous |  Page 167: Articles 1661-1670  | Next

The Impact of COVID-19 Lockdowns on Mental Health: A Comparative Study
Orgad, K.
10.1101/2024.09.02.24312962 — Posted: 2024-09-04
Protective Effects of Psychiatric Medications against COVID-19 Mortality Before Vaccines
Machado-Vieira, R., Krause, T. M., Jones, G., Teixeira, A. L., Shahani, L. R., Lane, S. D., Soares, J. C., Truong, C.
10.1101/2024.09.02.24312967 — Posted: 2024-09-04
Exploring COVID-19 Pandemic Perceptions and Vaccine Uptake among Community Members and Primary Healthcare Workers in Nigeria: A Mixed Methods Study.
Bakare, A. A., Sogbesan, A., Herzig Van Wees, S. A., Salako, J. A., Bakare, D., Olojede, O. E., Akinsola, K., Bakare, O. R., Falade, A. G., King, C.
10.1101/2024.09.02.24312966 — Posted: 2024-09-04
Short-term and Long-Term Healthcare Costs Attributable to diagnosed COVID-19 in Ontario; Canada: A Population-Based Matched Cohort Study
Sander, B., Mishra, S., Swayze, S., Sahakyan, Y., Duchen, R., Quinn, K. L., Janjua, N. Z., Sbihi, H., Kwong, J. C.
10.1101/2024.09.04.24313064 — Posted: 2024-09-04
Structural and molecular basis of the epistasis effect in enhanced affinity between SARS-CoV-2 KP.3 and ACE2
Feng, L., Sun, Z., Zhang, Y., Jian, F., Yang, S., Yu, L., Wang, J., Shao, F., Wang, X., Cao, Y.
10.1101/2024.09.03.610799 — Posted: 2024-09-04
Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants.
Ashley, C. L., Bloul, M., Alca, S., Smith, L., Jin, W., Khoury, D., Counoupas, C., Davenport, M. P., Triccas, J. A., Steain, M.
10.1101/2024.09.01.610733 — Posted: 2024-09-04
Hyperbaric Oxygen Therapy for Long COVID: 3-Month Follow up Results from a Prospective Registry of 232 patients
van Berkel, J., Lalieu, R. C., Joseph, D. R., Hellemons, M. E., Lansdorp, N. A.
10.1101/2024.09.02.24312948 — Posted: 2024-09-03
Chronic post-COVID neuropsychiatric symptoms (PCNPS) persisting beyond one year from being infected during the Omicron wave
Chau, S. W. H., Chue, T. M., Lam, T. C., Lai, Y. L., Chan, R. N. Y., Wong, P. W., Li, S. X., Liu, Y., Chan, J. W., Chan, P. K.-s., Lai, C. K.-C., Leung, T. W., Wing, Y. K.
10.1101/2024.09.01.24312691 — Posted: 2024-09-03
Global Health Security Index Scores are associated with Covid-19 Pandemic Health and Macroeconomic Outcomes
Boyd, M. J., Baker, M. G. J., Wilson, N.
10.1101/2024.09.02.24312964 — Posted: 2024-09-03
SARS-CoV-2 Mediated Inhibition Of Respiratory Syncytial Virus
Thornhill, E. M., Verhoeven, D.
10.1101/2024.09.02.610835 — Posted: 2024-09-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).